Xencor | Despesas Operacionais



Operating Expenses Alterar Data
AbbVie USD 9.71B 96M 2025-06
Alnylam Pharmaceuticals USD 789.89M 213.78M 2025-06
Amgen USD 6.52B 337M 2025-06
Arrowhead Research USD 193.32M 31.81M 2025-06
AstraZeneca USD 10.95B 1.04B 2025-06
Biogen USD 1.79B 326.1M 2025-06
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Cytokinetics USD 178.28M 21.06M 2025-06
GlaxoSmithKline GBP 5.96B 663M 2025-06
J&J USD 16.8B 8.54B 2025-06
MacroGenics USD 35.94M 20.58M 2024-12
Merck USD 9.44B 217M 2025-06
Novartis USD 9.97B 1.02B 2025-06
Pfizer USD 11.62B 1.58B 2025-06
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Roche Holding CHF 11.43B 1.48B 2024-12
Xencor USD 76.78M 865K 2025-06


Xencor Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.